Clinical Research on Retinal Neovascularization of Diabetic Retinopathy

NCT01229540 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL

Last updated 2010-10-27

No results posted yet for this study

Summary

Retinal neovascularization of diabetic retinopathy might be associated with genetic risk factors and environmental risk factors.

Conditions

  • The Mechanism of Retinal Neovascularization of Diabetic
  • Retinopathy.

Interventions

GENETIC

genetic analyzer

Sponsors & Collaborators

  • Tianjin Medical University

    lead OTHER

Eligibility

Min Age
45 Years
Max Age
74 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01229540 on ClinicalTrials.gov